Identifying the third dimension in 2D fluoroscopy to create 3D cardiac maps.

Three-dimensional cardiac mapping is important for optimal visualization of the heart during cardiac ablation for the treatment of certain arrhythmias. However, many hospitals and clinics worldwide cannot afford the high cost of the current mapping systems. We set out to determine if, using predefined algorithms, comparable 3D cardiac maps could be created by a new device that relies on data generated from single-plane fluoroscopy and patient recording and monitoring systems, without the need for costly equipment, infrastructure changes, or specialized catheters. The study included phantom and animal experiments to compare the prototype test device, Navik 3D, with the existing CARTO 3 System. The primary endpoint directly compared: (a) the 3D distance between the Navik 3D-simulated ablation location and the back-projected ground truth location of the pacing and mapping catheter electrode, and (b) the same distance for CARTO. The study's primary objective was considered met if the 95% confidence lower limit was greater than 0.75% for the Navik 3D-CARTO difference between the 2 distances, or less than or equal to 2 mm. Study results showed that the Navik 3D performance was equivalent to the CARTO system, and that accurate 3D cardiac maps can be created using data from equipment that already exists in all electrophysiology labs.

[1]  Mark E. Josephson,et al.  Nonfluoroscopic, in vivo navigation and mapping technology , 1996, Nature Medicine.

[3]  V. Fuster,et al.  Guide to Anticoagulant Therapy: Heparin: A Statement for Healthcare Professionals From the American Heart Association , 2001, Circulation.

[4]  Masood Akhtar,et al.  Mapping techniques for atrial fibrillation ablation. , 2007, Current problems in cardiology.

[5]  Silvia G Priori,et al.  ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Co , 2003, Circulation.

[6]  J. Pearlman,et al.  Localization ofBreakthrough Site ofCanine Monomorphic Ventricular Tachycardia by Pacemapping , 1991 .

[7]  Anne Rougee,et al.  Geometrical calibration for 3D x-ray imaging , 1993, Medical Imaging.

[8]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[9]  R Lazzara,et al.  Inverse relationship between electrode size and lesion size during radiofrequency ablation with active electrode cooling. , 1998, Circulation.

[10]  B. Efron The jackknife, the bootstrap, and other resampling plans , 1987 .

[11]  D. Packer,et al.  Three‐Dimensional Mapping in Interventional Electrophysiology: Techniques and Technology , 2005, Journal of cardiovascular electrophysiology.

[12]  Wolters Kluwer,et al.  Hrs/ehra/ecas Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design: a Report of the Heart Rhythm Society (hrs) Task Force , 2022 .

[13]  A. Goren,et al.  Quality of Life, Activity Impairment, and Healthcare Resource Utilization Associated with Atrial Fibrillation in the US National Health and Wellness Survey , 2013, PloS one.

[14]  José Jalife,et al.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation , 2012, Heart rhythm.

[15]  Hugh Calkins,et al.  Radiation Exposure During Catheter Ablation of Atrial Fibrillation , 2004, Circulation.

[16]  J. Ruskin,et al.  Localization of Breakthrough Site of Canine Monomorphic Ventricular Tachycardia by Pacemapping: A Vectorial Approach , 1991, Circulation.

[17]  S. Zeger,et al.  Longitudinal data analysis using generalized linear models , 1986 .

[18]  D. Altman,et al.  Agreement Between Methods of Measurement with Multiple Observations Per Individual , 2007, Journal of biopharmaceutical statistics.